In a major article for Pharmaceutical Market Europe, SynaptixBio explains the science behind gene silencing technologyDr Dan WilliamsJan 301 min readRead SynaptixBio's latest news about gene silencing in PME here.
Drug Target Review features an insightful article by Dan Williams that explores the extraordinary achievements of AI in drug design
Technology Networks features a major interview with Dr Uwe Meya, SynaptixBio’s CMO, in which the issues around organising, funding, and conducting clinical trials for rare diseases are discussed.
Dan Williams contributes to a major article for Inside Precision Medicine, in which several US families with a child living with H-ABC discuss their journey to a diagnosis
